Literature DB >> 688722

Formation of a thiomethyl metabolite of phenacetin and acetaminophen in dogs and man.

A Klutch, W Levin, R L Chang, F Vane, A H Conney.   

Abstract

Conjugates of 3-methylthio-4-hydroxyactanilide were found in the urine of dogs and humans treated with phenacetin (4-ethoxyacetanilide) or acetaminophen (4-hydroxyacetanilide). About 1% to 3% of the administered dose was excreted as this thiomethyl metabolite after administration of phenacetin or acetaminophen to dogs. An average of 0.39% of the dose was excreted in the urine as 3-methylthio-4-hydroxyacetanilide conjugates after administration of phenacetin to several subjects, and an average of 0.66% of the dose was excreted as this metabolite in the urine after administration of acetaminophen to humans. The possibility that the thiomethyl metabolite is derived from a mercapturic acid conjugate or an N-hydroxy derivative of phenacetin or acetaminophen is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 688722     DOI: 10.1002/cpt1978243287

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  The metabolism and toxicity of paracetamol in Sprague-Dawley and Wistar rats.

Authors:  S J Hart; I C Calder; J D Tange
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

Review 2.  Paracetamol poisoning in children and hepatotoxicity.

Authors:  A Penna; N Buchanan
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

Review 3.  Kinetics and metabolism of paracetamol and phenacetin.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of paracetamol.

Authors:  J A Forrest; J A Clements; L F Prescott
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

5.  Intrahepatic delivery of glutathione by conjugation to dextran.

Authors:  Y Kaneo; Y Fujihara; T Tanaka; Y Kozawa; H Mori; S Iguchi
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.